What causes infertility in men

What It Is

Male infertility refers to a man's inability to impregnate a female partner after at least one year of regular, unprotected sexual intercourse. It represents approximately 30-50% of infertility cases in couples seeking reproductive assistance. The condition can result from problems with sperm production, sperm function, or sperm delivery, affecting millions of men worldwide. Male infertility diagnosis typically involves a comprehensive medical evaluation including semen analysis, hormone testing, and physical examination of the reproductive tract.

The concept of male infertility has been recognized since ancient times, though scientific understanding advanced significantly in the 20th century. In 1677, Dutch scientist Antonie van Leeuwenhoek first observed human sperm using an early microscope, marking the beginning of modern reproductive science. The World Health Organization established standardized semen analysis parameters in 1987, providing consistent diagnostic criteria across medical institutions globally. Modern fertility treatments for male infertility emerged in the 1980s with the development of in vitro fertilization and intracytoplasmic sperm injection techniques.

Male infertility encompasses several distinct categories based on semen analysis results: oligospermia (low sperm count), asthenospermia (poor sperm motility), and teratospermia (abnormal sperm morphology). Many men experience a combination of these conditions, known as oligoasthenoteratospermia (OAT). Pretesticular causes affect sperm production, testicular causes involve damage to the testes themselves, and post-testicular causes obstruct sperm delivery. Some cases are classified as idiopathic when no specific cause can be identified despite thorough investigation.

How It Works

Sperm production begins in the seminiferous tubules of the testes, where specialized cells called Leydig cells produce testosterone and Sertoli cells nurture developing sperm cells. The process, called spermatogenesis, typically takes 74 days from initial cell division to mature sperm release. Hormonal signals from the pituitary gland, including follicle-stimulating hormone (FSH) and luteinizing hormone (LH), regulate this complex biological process. Any disruption in hormone signaling, testicular function, or sperm transport can result in reduced fertility.

Varicoceles, enlarged veins in the scrotum similar to varicose veins in the legs, represent one of the most common correctable causes of male infertility. A study published in Fertility and Sterility found that 40% of men with primary infertility have varicoceles compared to 15% of fertile men. The condition impairs testicular temperature regulation and blood flow, reducing sperm quality and quantity. Surgical correction of varicoceles has shown success rates of 30-50% for improving semen parameters and achieving natural pregnancy.

Hormonal imbalances significantly impact male fertility through disruption of the hypothalamic-pituitary-gonadal axis. Testosterone deficiency (hypogonadism) directly reduces sperm production and sexual function, affecting approximately 5-10% of infertile men. Hyperprolactinemia, elevated prolactin levels often caused by pituitary tumors, can suppress testosterone production and reduce sperm motility. Thyroid disorders and adrenal insufficiency also affect reproductive hormones, with treatment of underlying conditions often restoring normal sperm parameters within 3-6 months.

Why It Matters

Male infertility significantly impacts the psychosocial well-being of affected men and their partners, with studies showing increased rates of depression, anxiety, and relationship stress. The economic burden is substantial, with fertility treatments costing couples $12,000-$25,000 per cycle in the United States. Untreated infertility can lead to medical complications if underlying conditions like hypogonadism or prostate disease go undiagnosed. Early diagnosis and intervention improve treatment success rates and quality of life outcomes for affected couples.

The prevalence of male infertility has increased across multiple developed nations, with sperm counts declining by approximately 1.16% annually since 1973 according to a 2017 meta-analysis. Environmental factors including pesticide exposure, air pollution, and microplastic contamination have been linked to declining male reproductive health. Industries from urology to reproductive endocrinology to andrological research have evolved significantly to address these trends. Companies like Merck, Pfizer, and specialized fertility clinics worldwide now invest billions in male infertility research and treatment development.

Male infertility treatment options continue to advance rapidly with emerging technologies like extended semen culture and sperm selection techniques. Next-generation sequencing now allows identification of genetic causes previously classified as idiopathic infertility. Regenerative medicine approaches including stem cell therapy show promise for restoring testicular function in animal studies. Precision medicine approaches personalized to individual genetic and hormonal profiles represent the future of male fertility care.

Common Misconceptions

A widespread myth claims that infertility is exclusively a female problem, yet male factors account for 30-50% of couple infertility cases. Many couples spend years pursuing female-focused treatments without identifying male infertility issues. The American Society for Reproductive Medicine emphasizes that both partners require evaluation in infertility workups. Recognizing male infertility as a major contributor has improved diagnostic efficiency and treatment outcomes for millions of couples.

Another misconception holds that male infertility is permanent and untreatable, when in reality many causes are correctable or manageable. Surgical repair of varicoceles restores fertility in 40-50% of cases, while hormonal treatments can restore sperm production in men with testosterone deficiency. Lifestyle modifications including weight loss, smoking cessation, and reduced heat exposure improve semen parameters in 20-30% of cases. Even in cases requiring assisted reproduction, modern techniques like intracytoplasmic sperm injection enable conception with very low sperm counts.

Many men believe that erectile dysfunction and infertility are the same condition, when they represent distinct reproductive issues with different causes and treatments. While some conditions like hypogonadism affect both, most infertility causes produce no sexual dysfunction symptoms. A man with excellent sexual function may have severe oligospermia, while another with erectile dysfunction may have normal sperm production. This distinction is crucial because treatment approaches differ significantly between these two conditions.